Avery Eriksson
Physician Assistant · Chesapeake, VANPI 1780194530
Payments from drug & device makers
Across 334 payments — averaging $18.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$952
- Pfizer$853
- AstraZeneca$699
- Novo Nordisk$685
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$414
- GSK$309
- plus $2K from 33 others
What the payments were for
- Food & beverage$6,217100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 57 | $952 |
| Pfizer | 41 | $853 |
| AstraZeneca | 34 | $699 |
| Novo Nordisk | 36 | $685 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 27 | $414 |
| GSK | 17 | $309 |
| Bayer | 11 | $207 |
| Lilly USA, LLC | 14 | $196 |
| Amgen | 12 | $180 |
| Astellas Pharma US Inc | 8 | $170 |
| Boehringer Ingelheim | 8 | $154 |
| Xeris Pharmaceuticals, Inc. | 5 | $154 |
| Johnson & Johnson | 7 | $141 |
| Exact Sciences | 5 | $94 |
| Otsuka America Pharmaceutical, Inc. | 4 | $88 |
| Novartis | 6 | $86 |
| Dexcom, Inc. | 4 | $71 |
| Organon | 3 | $64 |
| Abbott | 3 | $64 |
| Radius Health, Inc. | 3 | $63 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $57 |
| Corcept Therapeutics | 2 | $52 |
| Ultragenyx Pharmaceutical Inc. | 2 | $45 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $45 |
| Sanofi-aventis U.S. LLC | 2 | $42 |
| Inspire Medical Systems, Inc. | 2 | $37 |
| Biohaven Pharmaceuticals, Inc. | 2 | $36 |
| Endo USA, Inc. | 2 | $31 |
| Teva Pharmaceuticals USA, Inc. | 2 | $31 |
| Kyowa Kirin, Inc. | 1 | $28 |
| Stryker | 1 | $27 |
| Boston Scientific | 1 | $24 |
| Vifor Pharma, Inc. | 1 | $22 |
| Lundbeck LLC | 1 | $22 |
| Sanofi Pasteur Inc. | 1 | $17 |
| Medtronic | 1 | $17 |
| Pharming Healthcare, Inc. | 1 | $14 |
| Merck | 1 | $13 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $11 |
How this compares
$6,217 in reported general payments places this provider in the 95th percentile of 3,376 physician assistant providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 86 | $93,525 |
| JardianceEmpagliflozin | 49 | $71,489 |
| FarxigaDapagliflozin Propanediol | 53 | $57,998 |
| JanuviaSitagliptin Phosphate | 40 | $42,192 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 32 | $29,356 |
| TrulicityDulaglutide | 19 | $28,766 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 18 | $18,373 |
| LinzessLinaclotide | 14 | $17,121 |
| MounjaroTirzepatide | 12 | $13,196 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 16 | $11,054 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 55 | $4,380 |
| Humalog Kwikpen U-100Insulin Lispro | 19 | $3,156 |
| Atorvastatin Calcium | 374 | $2,104 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 68 | $1,547 |
| Rosuvastatin Calcium | 111 | $1,231 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $685 | $93,52586 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $699 | $87,35485 claims |
| Boehringer IngelheimJardiance | $154 | $71,48949 claims |
| MerckJanuvia, Janumet Xr | $13 | $60,56558 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $196 | $41,96231 claims |
| AbbVieLinzess | $952 | $17,12114 claims |
| GSKTrelegy Ellipta | $309 | $11,05416 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,376 physician assistant providers in Virginia.
Other physician assistant in Chesapeake
- Lindsay SeddonChesapeake$12K
- John DalessandroSalem$160K
- Jalal AlghabraFredericksburg$119K
- Jamie GiovanelliVirginia Beach$118K
- John CarterStaunton$90K
- Melissa AlcoxNorfolk$73K
- Lindsay TomReston$71K
- Robert HigginsonRichmond$66K
- Jameka McElroy-BrooklynArlington$65K
- Hillary HartungNorfolk$62K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.